Non-opioid Pain Patch Market Size

  • Report ID: 5423
  • Published Date: Sep 11, 2025
  • Report Format: PDF, PPT

Non-opioid Pain Patch Market Outlook:

Non-opioid Pain Patch Market size was valued at USD 998.64 million in 2025 and is set to exceed USD 1.86 billion by 2035, expanding at over 6.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of non-opioid pain patch is estimated at USD 1.06 billion.

The reason behind the growth is due to the growing burden of diabetes across the globe. Diabetic neuropathy may present as the initial symptom of diabetes caused by excessive blood sugar levels that harm the nerves resulting in pain and discomfort in the hands, feet, or limbs.

According to the World Health Organization (WHO), around 422 million individuals globally suffer from diabetes, and the disease is directly responsible for roughly 1.5 million fatalities annually.

The growing development of advanced products is believed to fuel the non-opioid pain patch market growth. For instance, A scientific team led by Duke University has created a biocompatible polymer patch surgical patch that dissolves after releasing non-opioid medicines and it is assumed that during the crucial period following surgery, the patch should be able to manage wound discomfort for three or four days.


Non-opioid-Pain-Patches-Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of non-opioid pain patch is estimated at USD 1.06 billion.

The global non-opioid pain patch market size crossed USD 998.64 million in 2025 and is likely to expand at a CAGR of over 6.4%, surpassing USD 1.86 billion revenue by 2035.

North America’s non-opioid pain patch market dominates with a 51% share by 2035, driven by the presence of key players leading to the development of new products.

Key players in the market include GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos